Thymosin Alpha-1 10 mg

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino-acid immunoregulatory peptide. It is studied for its role in modulating innate and adaptive immune responses, with reported immunomodulatory and antiviral properties.

For research use only. Not for human or veterinary consumption.

Please note, to maintain the quality and integrity of every product, all orders are fulfilled on a made-to-order basis. Please allow 7–14 days for processing and delivery. You will receive tracking details as soon as your order is dispatched.

Research Use Only.

This compound is supplied strictly for in vitro research purposes. It is not approved by the FDA and is not intended for human consumption, therapeutic, diagnostic, or veterinary use. By purchasing, you confirm you are a qualified researcher aged 18+.

Description

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino-acid immunoregulatory peptide. It is studied for its role in modulating innate and adaptive immune responses, with reported immunomodulatory and antiviral properties.

Key research areas

  • Cytokine production (interleukins, IFN-γ, IL-2)
  • Natural killer (NK) cell and CD4+/CD8+ T lymphocyte activity
  • Antigen presentation and immune regulation
  • Inflammation and tissue damage research

Product details

  • Class: Immunoregulatory peptide (28 amino acids)
  • Vial size: 100 mcg sterile lyophilised powder
  • Route used in protocols: subcutaneous, 1–3 times per week

For research use only. Not for human or veterinary consumption. Not approved by the FDA for the uses described. This information is provided for educational and scientific reference only and is not medical advice.

Shipping & Storage
Shipping: Ships within 48 hours. Temperature-appropriate packaging. Discreet labeling.
Lyophilized: Stable at −20°C for up to 24 months when kept dry and protected from light.
Reconstituted: Store at 2–8°C. Use within 28 days. Do not freeze after reconstitution.
Diluent: Bacteriostatic water (BW) recommended for multi-dose use. See Protocols.